Monthly Archives: August 2015

JOHNSON & JOHNSON LAWSUIT

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN SEEKING RECOVERY

Class Action Lawsuit Filed Against Johnson & Johnson Alleging Personal Products For Babies Are Mislabeled

According to a complaint filed on July 2, 2015, Johnson & Johnson falsely mislabels its Bedtime Bath and Bedtime Lotion products as being clinically proven to help babies sleep better.

If you or a family member have purchased Johnson & Johnson’s Bedtime Bath and/or Bedtime Lotion and did so relying on the assertion that it helps babies sleep better, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

JOHNSON & JOHNSON LAWSUIT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in consumer lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About The Class Action Lawsuit Against Johnson & Johnson

A Class Action complaint was filed against Johnson & Johnson Consumer Co., Inc. on July 2, 2015 in the Superior Court of New Jersey in Camden County alleging the defendants engaged in false and misleading advertising when it labeled Bedtime Bath and Bedtime Lotion products as being clinically proven to help babies sleep better when the product or products when used in conjunction with a soothing bedtime routine. The complaint states these assertions are present not only on the products’ labels but also on television, magazines and the internet. Plaintiff contends that she relied on the “clinically proven” benefits listed on the label when paying $1 more than other Johnson & Johnson baby products.

AZOR ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Filed Alleging Azor Causes Serious Gastrointestinal Problems

Plaintiff alleges Azor, used to treat high blood pressure, caused sprue-like enteropathy including severe diarrhea, weight loss and malnutrition.

If you or a family member has used Azor and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

AZOR ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Azor

Azor (olmesartan/amlopidine) is a combination of the drugs Benicar and Norvasc and is used to treat high blood pressure. Azor is manufactured by Daiichi Sankyo, Inc. and was approved by the FDA in 2007 for the treatment of high blood pressure. In 2013, the FDA issued a warning that Azor, and other drugs that contain olmesartan, may increase the risk of sprue-like enteropathy.

In 2014, a complaint was filed against Daiichi Sankyo, Inc. in the United States District Court for the Eastern District of Louisiana. The plaintiff alleges Azor caused him to develop sprue-like enteropathy which included severe diarrhea with substantial weight loss and malnutrition. Plaintiff claims the company failed to adequately research the possible side effects of Azor or warn the public of the risks associated with the drug.

SECONDARY EXPPOSURE TO ANDROGEL ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Secondary Exposure to AndroGel Can Cause Various Irregularities in Women and Children

Black-Box Warning Issued By the FDA for Secondary Exposure to AngroGel in Women and Children

If you or a family member has experienced secondary exposure to AndroGel and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit

About Secondary Exposure to AndroGel

AndroGel is used to treat low testosterone (“Low T”) and is prescribed as a testosterone-replacement drug, mostly to men who cannot produce enough amounts of the male hormone. It is a synthetic hormone in gel form that is absorbed through the skin and increases the total amount of testosterone in the body to a normal range.

AndroGel contains a Black-Box warning for secondary exposure to women and children. This warning states that women and children should avoid contact with any unwashed application sites or unwashed clothing of men using the drug. Women and children may show symptoms of secondary exposure to AndroGel including:

Enlargement of genitals
Early development of pubic hair in children
Increased erections
Increased libido
Aggressive behavior
Advanced bone age in children
Increased acne and body hair in women

2011-2015 KIA PANORAMIC SUNROOF ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Panoramic Sunroofs Spontaneously Shattering in Many 2011-2015 Kia Models

We are currently investigating what is a suspected defect causing the sunroofs of 2011-2015 Kia Sorento, Optima, Soul, Cadenza and Sportage to suddenly shatter.

If you or a family member have or have had any of the Kia models listed above and have experienced the spontaneous shattering of the sunroof, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

KIA PANORAMIC SUNROOF ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in defective products lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About 2011-2015 Kia Panoramic Sunroof Investigation

Gilman Law, LLP is currently investigating the claims made by owners of 2011-2015 Kia vehicles of a defect which causes the panoramic sunroofs to shatter unexpectedly. There have been more than 80 drivers who have reported their sunroofs suddenly exploding since 2009. These events are occurring while the drivers were operating their vehicles and under ordinary weather conditions. This event could lead to injuries from the scattered glass and lead to a crash causing devastating injuries to the driver and others on the road. The defect is believed to be caused from the unlaminated tempered glass used in the sunroofs. According to drivers’ reports, the sunroofs are shattering when the cars are relatively new and still under the manufacturer’s warranty. Amazingly, Kia cannot guarantee that the replacement sunroof will not suffer the same fate.

SEARS’ CRAFTSMAN RIDING LAWN MOVERS AND LAWN TRACTORS SAFETY DEFECT ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

A Class Action Lawsuit Filed Against Sears Alleging the Concealment of a Major Defect in Craftsman Riding Lawn Mowers and Lawn Tractors

According to a class action complaint filed May 21, 2015, Sears designed, manufactured and sold Craftsman riding lawnmowers and lawn tractors knowing they had a dangerous safety defect. This defect caused fuel to leak on moving parts that have caused the lawnmowers and tractors to catch fire while in use or shortly thereafter.

If you or a family member has purchased a Craftsman riding lawn mower or tractor and it has leaked fuel and/or caught fire, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in defective products lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Sears’ Craftsman Riding Lawn Mowers and Lawn Tractors

A class action complaint was filed on May 21, 2015 in the United States District Court for the Northern District of Illinois alleging that Sears’ Craftsman riding lawnmowers and lawn tractors contain a serious and dangerous defect. The complaint lists the riding lawnmowers and tractors sold by Sears that contain the defect are, but not limited to, Craftsman Models 917.20383, 917.288515, YTS 3500 Model No. 917.27660, GT 5000 Model No. 917.289453. It is alleged that these lawnmowers have a fuel line that is not adequately secured and can often dislodge from the gas tank during use. The fuel line and electrical components are near the lawnmowers’ drive belts and pulleys so that when the fuel line breaks away from the fuel tank or is worn down from the friction of the moving parts and/or if the electrical components are worn down from the friction of the moving parts, fuel drips onto the mowing bed and catches fire. The fire caused by the fuel leak can occur while using the lawnmower or just after they are stored after use. The complaint alleges Sears knew or should have known about the defect and concealed it from and failed to warn consumers.

DIABETES MEDICATIONS ONGLYZA AND NESINA ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Onglyza and Nesina May Increase the Risks of Pancreatic Cancer, Thyroid Cancer and Heart Failure

A FDA advisory committee voted to update the label for Onglyza to warn patients of an increased risk of heart failure. These drugs have also been linked to pancreatic cancer and thyroid cancer.

If you or a family member has taken Onglyza and/or Nesina and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its

About Onglyza and Nesina

Onglyza (saxagliptin), manufactured by AstraZeneca and Bristol-Myers Squibb, and Nesina (alogliptin), manufactured by Takeda Pharmaceuticals, are approved by the FDA to help those with diabetes maintain a healthy blood sugar level. These drugs belong to a class called incretin mimetics, which stimulates the production of insulin to help regulate blood sugar in patients with type-2 diabetes.

The makers of Onglyza funded a study which found patients who used the drug had a higher rate of hospitalizations due to heart failure. In April 2015, an advisory committee to the FDA voted to update the label for Onglyza to add information regarding the increased risk of heart failure.

A March 2013 study showed a strong link between these diabetes medications and pancreatic cancer. This study also showed that those who had taken these medications had a pancreas that was 40% larger than normal and had a 6x increase of pre-cancerous cell growth and tumors. These tumors can become cancerous. In 2011, the FDA issued a safety warning after studies showed a higher rate of thyroid cancer in rodents taking incretin mimetics.

JANUVIA, BYETTA, JANUMET AND VICTOZA ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuits Filed Against the Makers of the Diabetes Drugs Januvia, Byetta, Janument and Victoza Claiming They Cause Serious Side Effects Such as Pancreatitis and Pancreatic Cancer

According to class action lawsuits filed nationwide against Merck, Amylin, Eli Lilly, Bristol-Myers Squibb and Novo Nordisk A/S, the makers of the diabetes drugs Januvia, Byetta, Janument and Victoza, the companies marketed these medicines as safe knowing they were dangerous and failed to warn the public of the increased risks of pancreatic cancer and pancreatitis.

If you or a family member has taken Januvia, Byetta, Janumet and/or Victoza and have been injured, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in lawsuits involving defective drugs.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Januvia, Janument, Byetta and Victoza

Januvia, Byetta, Janumet and Victoza are prescription drugs used to treat Type 2 diabetes. Merek is the maker of Januvia and Janument. Byetta is manufactured Amylin, Eli Lilly and Bristol-Myers Squibb. Victoza is manufactured by Novo Nordisk A/S. The FDA approved the use of Byetta, Januvia, Janument and Victoza in 2005, 2006, 2007 and 2010, respectively. All of these drugs are classified as incretin mimetics. The FDA has issued warnings stating these drugs can cause serious medical problems such as pancreatic diseases.

Plaintiffs in class action lawsuits filed nationwide against the makers of these drugs have claimed they developed pancreatitis and pancreatic cancer due to the use of the drugs. Plaintiffs also allege the drugmakers knew or should have known about the dangerous side effects, failed to test the drugs adequately and monitor the side effects and failed to warn the public of the increased risks of developing pancreatic diseases and cancer.

ALERT: HIGH LEVELS OF ARSENIC FOUND IN NUMEROUS WINES PRODUCED IN CALIFORNIA

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Alleging Numerous California Wineries Knowingly Distributed and Sold Wine Containing High Levels of Arsenic

According to the class action complaint filed March 20, 2015, a number of California wineries produced and marketed wines which contained high levels of inorganic arsenic. Inorganic arsenic has proven to cause cancer and contributes to numerous other fatal ailments. Despite this, the defendants continued to manufacture, market and sell these wines while failing to warn the public of the dangers of ingesting inorganic arsenic.

If you or a family member has consumed any of the wines listed below and have become ill, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in toxic substance lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Arsenic in Many Wines Produced in California

A class action complaint was filed on March 20, 2015 in the United States District Court for the Northern District of Florida alleging a number of California wineries of manufacturing and selling wines which, as the result of testing from three different laboratories, contain dangerously high levels of inorganic arsenic. According to the complaint, ingestion of high levels of inorganic arsenic can lead to cancer and a host of other debilitating and/or fatal diseases. Despite this, the wineries listed in the complaint continued to manufacture and sell these wines and failed to warn the public of the potential dangers of inorganic arsenic ingestion.

The following wineries and their wines are subject to the class action lawsuit:

The Wine Group, Inc.

Franzia wine: Vintner Select White Grenache, White Zinfandel, Vintner Select White Merlot and Vintner Select Burgundy
Mogen David wine: Concord and Blackberry wine
Concannon wine: Glen Ellen Reserve Pinot Grigio, Selected Vineyards Pinot Noir and Glen Ellen Reserve Merlot
Flipflop wine: Pinot Grigio, Moscato and Cabernet Sauvignon
Tribuno wine: Sweet Vermouth
Corbett Canyon wine: Pinot Grigio and Cabernet Sauvignon
Alamaden wine: Heritage White Zinfandel; Heritage Moscato; Heritiage Chardonay; Mountain Burgundy; Mountain Rhine and Mountain Chablis
Oak Leaf wine: White Zinfandel
Foxhorn wine: White Zinfandel
Trapiche wine: Malbec
Fisheye wine: Pinot Grigio
Bay Bridge wine: Chardonay
Cupcake wine: Malbec

Sutter Home Winery, Inc.

Ménage a Trois wine: Pinot Grigio, Moscato, While Blend, Chardonnay, Rose, Cabernet Sauvignon and California Red Wine
Wine Cube Wine: Moscato, Pink Moscato, Pinot Grigio, Chardonnay, Red Sangria, Sauvignon Blanc and Cabernet Sauvignon/Shiraz
Bandit wine: Pinot Grigio, Chardonnay and Cabernet Sauvignon
Sutter Home Wine: Sauvignon Blanc, Gewurztraminer, Pink Moscato, Pinot Grigio, Moscato, Chenin Blanc, Sweet Red, Riesling, White Merlot, Merlot, White Zinfandel and Zinfandel
SeaGlass wine: Sauvignon Blanc

Wine Estates Americas Co.

Beringer wine: White Merlot, White Zinfandel, Red Moscato and Refreshingly Sweet Moscato

Constellation Wines and US and Smith & Hook Winery Corporation

HRM Rex-Goliath wine: Moscato
Simply Naked wine: Moscato
Vendange wine: Merlot and White Zinfandel
Cooks wine: Spumante
Richard Wild Irish Rose wine: Red wine

Fetzer Vineyards

Korbel wine: Sweet Rose Sparkling Wine and Extra Dry Sparkling Wine

Mason Cellars and Oakville Winery

Pomelo wine: Sauvignon Blanc

Winery Exchange

Acronym wine: Gr8rw Red Blend
Arrow Creek wine: Coastal Series Cabernet Sauvignon
Hawkstone wine: Cabernet Sauvignon

Treasury Wine Estates

Colores Del Sol wine: Malbec

Don Sebastiani & Sons

Smoking Loon wine: Viognier

Bronco Wine Company

Charles Shaw wine: White Zinfandel

Jean-Claude Boisset Wines

R. Collection by Raymond wine: Chardonay

COX COMMUNICATIONS INC. LAWSUIT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN SEEKING RECOVERY

Class Action Lawsuit Filed Against Cox Communications Alleging False and Misleading Advertisement of Fees Charged For Certain Cable Television Service Tiers

According to a complaint filed on July 7, 2015, Cox Communications charged its customers unauthorized fees for its “Advanced TV” package.

If you or a family member currently subscribe to or have subscribed to “Adavnced TV” tier with Cox Communications and were charged extra and/or hidden fees, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

COX COMMUNICATIONS INC. LAWSUIT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in product liability and consumer lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About The Class Action Lawsuit Against Cox Communications

A Class Action complaint was filed against Cox Communications, Inc. on July 7, 2015 in the United States District Court for the Southern District of California alleging the defendants engaged in false and misleading advertising when it charged its subscribers of the “Advanced TV” tier extra, hidden fees. The complaint claims Cox Communications advertised prices for television services as all-inclusive, except for government-mandated fees, when it actually charged their subscribers additional and unauthorized fees that the company failed to disclose in its advertisements. The plaintiffs claim Cox Communications deliberately used confusing labeling of these fees for “Advanced TV” and thus was able to make sizable profits.

SIMILAC® ADVANCE ORGANIC INFANT FORMULA ALERT

Leave a reply

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Class Action Lawsuit Filed Against Abbott Laboratories Alleging False and Misleading Representations on Labeling of Similac® Advance Organic Infant Formula

According to a complaint filed on May 15, 2015, Abbott’s Similac® Advance “Organic” Infant Formula contains a substantial amount of ingredients prohibited in organic foods. Over half of the ingredients in the “organic” formula are alleged to contain irradiated substances, synthetic compounds or are produced from hazardous products.

If you or a family member has purchased Similac® Advance Organic Infant Formula and did so believing the product was indeed organic, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM

SIMILAC® ADVANCE ORGANIC INFANT FORMULA ALERT

Our firm is vigorously pursuing this matter.
Our clients have received millions of dollars in product liability and consumer lawsuits.
No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About The Class Action Lawsuit Against Abbott Laboratories

A Class Action complaint was filed against Abbott Laboratories on May 15, 2015 in the United States District Court for the Eastern District of New York alleging the defendant engaged in false and misleading advertising when it labeled its Similac® Advance Organic Infant Formula as organic. Plaintiffs allege over half of the ingredients in the “Organic” formula contain substances prohibited in organic foods. Because of these false and misleading statements, Plaintiffs allege that Abbott Laboratories was able to ask for and obtain a premium price for the formula marketed under the organic guise and make sizable profits. Plaintiffs further allege that the Defendant violated various consumer protection states laws.